Aptinyx Inc.

Home » Aptinyx Inc.

IPO

Aptinyx Inc.

We are a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel, proprietary, synthetic small molecules for the treatment of brain and nervous system disorders.

Symbol

APTX

Price Range
$14.00 - $16.00

Final Shares
5,333,333

Anticipated Date
TBD

Underwriters
J.P. Morgan, Cowen, Leerink Partners, BMO Capital Markets

To view the prospectus for Aptinyx Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253